Payer and Pricing Assessment for Novel Hemophilia A Therapy
Discover how Unimrkt Healthcare conducted payer and pricing assessment for a novel Hemophilia A therapy. Leveraging desk and primary research across the USA and EU5, we identified payer perspectives on pricing scales, contract agreements, and access hurdles. Results were delivered with actionable insights to support client strategies. https://unimrkthealth.com/case....-studies/payer-and-p
Like
Comment
Share
